NPR1 and infection: Blocking NPR1 degradation pharmacologically with proteasome inhibitors or genetically by mutation of Cullin 3 resulted in accumulation of NPR1 monomer, moderate induction of NPR1 target genes, and elevated resistance to pathogen infection (Spoel et al., 2009).